Vycor Medical operating profit falls 15% to $27,424; revenue drops 19% to $414,895
VYCO•For the three months ended September 30, 2026, Vycor Medical’s operating profit fell 15% to $27,424 and revenue declined 19% to $414,895. Net loss available to common stockholders widened to $161,447 for the quarter, while the nine-month net loss narrowed to $325,812.
1. Quarterly results
Vycor Medical reported operating profit of $27,424, down 15%, and revenue of $414,895, down 19%, for the three months ended September 30, 2026. Its net loss available to common stockholders widened to $161,447 for the quarter, while the nine-month net loss narrowed to $325,812.
2. Study count
Four new peer-reviewed studies published during 2026 brought the total for the ViewSite Brain Access System to 54.
